Goldman Sachs cuts Nanobiotix stake to 3.78%
Goldman Sachs cut its stake in Nanobiotix SA to 3.78% after an off-market sale of shares, the company said in a filing on Sept. 21. The holding fell to 1,921,176 shares, equal to 3.78% of share capital and 3.52% of voting rights.